[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10131 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                               H. R. 10131

  To amend the Patient Protection and Affordable Care Act to include 
      fertility treatment and care as an essential health benefit.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 15, 2024

Ms. Underwood introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To amend the Patient Protection and Affordable Care Act to include 
      fertility treatment and care as an essential health benefit.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health Coverage for Inclusive and 
Valued Families Act of 2024'' or the ``Health Coverage for IVF Act of 
2024''.

SEC. 2. INCLUDING FERTILITY TREATMENT AND CARE AS AN ESSENTIAL HEALTH 
              BENEFIT.

    (a) In General.--Section 1302(b) of the Patient Protection and 
Affordable Care Act (42 U.S.C. 18022(b)) is amended--
            (1) in paragraph (1)--
                    (A) in the matter preceding subparagraph (A), by 
                striking ``paragraph (2)'' and inserting ``paragraphs 
                (2) and (6)''; and
                    (B) by adding at the end the following new 
                subparagraph:
                    ``(K) Fertility treatment and care.''; and
            (2) by adding at the end the following new paragraph:
            ``(6) Fertility treatment and care defined.--For purposes 
        of paragraph (1)(K), the term `fertility treatment and care' 
        means the following medically appropriate items and services 
        furnished to an individual regardless of whether such 
        individual has a diagnosis of infertility:
                    ``(A) Preservation of human oocytes, sperm, or 
                embryos for later reproductive use.
                    ``(B) Artificial insemination, including 
                intravaginal insemination, intracervical insemination, 
                and intrauterine insemination.
                    ``(C) Assisted reproductive technology, including 
                in vitro fertilization and other treatments or 
                procedures in which reproductive genetic material, such 
                as oocytes, sperm, fertilized eggs, and embryos, are 
                handled, when clinically appropriate.
                    ``(D) Genetic testing of embryos.
                    ``(E) Medications prescribed or obtained over-the-
                counter, as indicated for fertility.
                    ``(F) Gamete donation.
                    ``(G) Such other information, referrals, 
                treatments, procedures, medications, laboratory 
                testing, technologies, and services relating to 
                fertility as the Secretary determines appropriate.''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to plan years beginning on or after the date that is 1 year after 
the date of the enactment of this Act.
                                 <all>